Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  


SHILPA MEDICARE Gains 6%; BSE HEALTHCARE Index Up 0.2%
Thu, 14 Nov 9:37

SHILPA MEDICARE Gains 6%; BSE HEALTHCARE Index Up 0.2%Image source: DNY59/www.istockphoto.com

SHILPA MEDICARE share price has zoomed 6% and is presently trading at Rs 853.8.

Meanwhile, the BSE HEALTHCARE index is at 42,509.7 (up 0.2%).

Among the top gainers in the BSE HEALTHCARE index today are FORTIS HEALTHCARE (up 2.8%) and Natco Pharma (up 2.7%).

ASTRAZENECA PHARMA (down 2.9%) and SUVEN PHARMACEUTICALS (down 1.8%) are among the top losers today.

Over the last one year, SHILPA MEDICARE has moved up from Rs 371.5 to Rs 853.8, registering a gain of Rs 482.4 (up 129.9%).

On the other hand, the BSE HEALTHCARE index has moved up from 29,042.6 to 42,509.7, registering a gain of 46.4% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 180.7%), SUVEN PHARMACEUTICALS (up 111.3%) and Glenmark Pharma (up 101.3%).

For Investors: Our Big Prediction

What About the Benchmark Indices?

The BSE Sensex is at 77,776.5 (up 0.1%).

The top gainers among the BSE Sensex today are HCl Tech. (up 1.6%) and NTPC (up 0.7%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.

In the meantime, NSE Nifty is at 23,586.6 (up 0.1%). Eicher Motor and HCl Tech. are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,259.5 to 77,776.5, registering a gain of 12,517.0 points (up 19.2%).

SHILPA MEDICARE Financial Update...

SHILPA MEDICARE net profit grew 519.2% YoY to Rs 176 million for the quarter ended June 2024, compared to a profit of Rs 28 million a year ago. Net sales rose 12.4% to Rs 2,925 million during the period as against Rs 2,602 million in April-June 2023.

For the year ended March 2024, SHILPA MEDICARE reported 203.4% increase in net profit to Rs 320 million compared to net loss of Rs 309 million during FY23. Revenue of the company grew 9.7% to Rs 11,516 million during FY24.

The current Price to earnings ratio of SHILPA MEDICARE, based on rolling 12 month earnings, stands at 162.2.


Equitymaster requests your view! Post a comment on "SHILPA MEDICARE Gains 6%; BSE HEALTHCARE Index Up 0.2%". Click here!